DK0526192T3 - hexapeptid - Google Patents

hexapeptid

Info

Publication number
DK0526192T3
DK0526192T3 DK92306942.1T DK92306942T DK0526192T3 DK 0526192 T3 DK0526192 T3 DK 0526192T3 DK 92306942 T DK92306942 T DK 92306942T DK 0526192 T3 DK0526192 T3 DK 0526192T3
Authority
DK
Denmark
Prior art keywords
agent
alkyl group
hexapeptide
isoleucine
valine
Prior art date
Application number
DK92306942.1T
Other languages
Danish (da)
English (en)
Inventor
Tadami Fujiwara
Masaki Aburada
Michio Nagasawa
Sakae Amagaya
Tsutomu Oyama
Original Assignee
Tsumura & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsumura & Co filed Critical Tsumura & Co
Application granted granted Critical
Publication of DK0526192T3 publication Critical patent/DK0526192T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK92306942.1T 1991-07-30 1992-07-30 hexapeptid DK0526192T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21141691 1991-07-30

Publications (1)

Publication Number Publication Date
DK0526192T3 true DK0526192T3 (da) 1997-07-28

Family

ID=16605597

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92306942.1T DK0526192T3 (da) 1991-07-30 1992-07-30 hexapeptid

Country Status (11)

Country Link
US (1) US5393740A (de)
EP (1) EP0526192B1 (de)
JP (1) JP2803477B2 (de)
KR (1) KR100251496B1 (de)
AT (1) ATE149518T1 (de)
AU (1) AU661003B2 (de)
CA (1) CA2074967A1 (de)
DE (1) DE69217763T2 (de)
DK (1) DK0526192T3 (de)
ES (1) ES2101037T3 (de)
GR (1) GR3023058T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007705A1 (en) * 1993-09-15 1995-03-23 The Regents Of The University Of California Method for inhibiting vascular leakage and anti-inflammatory compounds
US5955430A (en) * 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
JPH0848634A (ja) * 1994-08-05 1996-02-20 Akio Okamoto 角膜治療剤
GB9425582D0 (en) * 1994-12-19 1995-02-15 Iaf Biochem Int Peptides having immunomodulatory activity
US6214790B1 (en) * 1998-04-10 2001-04-10 Mayo Foundation For Medical Education And Research Neo-tryptophan
US7087575B2 (en) * 2002-07-18 2006-08-08 Mayo Foundation For Medical Education And Research Treating the effect of nicotine
EP1768951A4 (de) * 2004-06-17 2011-06-15 Musc Found For Res Dev Nicht-natürliche aminosäuren
WO2006085417A1 (ja) * 2005-02-10 2006-08-17 Nagase Chemtex Corporation 生活習慣病を予防する食品
WO2007100718A2 (en) * 2006-02-24 2007-09-07 Denise Barbut Neurotensin receptor agonists and opioid receptor agonists
WO2010085661A1 (en) * 2009-01-23 2010-07-29 Musc Foundation For Reasearch Development Modified peptides and their use
WO2014039074A2 (en) * 2012-09-04 2014-03-13 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic compositions and related methods
CN105541642A (zh) * 2016-01-11 2016-05-04 罗梅 一种手性（s）-亮氨醇盐酸盐的合成方法
CZ309857B6 (cs) * 2022-03-31 2023-12-20 Contipro A.S. Hexapeptid, kompozice zahrnující tento hexapeptid a jejich topické použití

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411890A (en) * 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US4110321A (en) 1976-07-12 1978-08-29 Folkers Karl Synthetic tridecapeptide [Gln4 ]-neurotensin having hormonal activity
US4425269A (en) * 1982-06-07 1984-01-10 Merck & Co., Inc. Metabolically protected analogs of neurotensin
IT1190389B (it) * 1985-09-19 1988-02-16 Eniricerche Spa Esapeptidi ad attivita' ipotensiva
JP2714425B2 (ja) * 1988-03-11 1998-02-16 エーザイ株式会社 ポリペプチド
FI890918A (fi) * 1988-03-11 1989-09-12 Eisai Co Ltd Polypeptider.

Also Published As

Publication number Publication date
EP0526192A3 (en) 1993-12-08
JP2803477B2 (ja) 1998-09-24
AU661003B2 (en) 1995-07-13
EP0526192B1 (de) 1997-03-05
KR930002373A (ko) 1993-02-23
ES2101037T3 (es) 1997-07-01
DE69217763D1 (de) 1997-04-10
KR100251496B1 (ko) 2000-05-01
ATE149518T1 (de) 1997-03-15
CA2074967A1 (en) 1993-01-31
US5393740A (en) 1995-02-28
AU2065792A (en) 1993-02-04
EP0526192A2 (de) 1993-02-03
JPH05194590A (ja) 1993-08-03
DE69217763T2 (de) 1997-07-10
GR3023058T3 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
ES2101037T3 (es) Hexapeptido.
KR930004280A (ko) 경구 활성 엘라스타제 억제제
US4692459A (en) Anti-hypertensive agents
TR200100438T2 (tr) Hepatit C inhibitörü peptitler
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
ES2164218T3 (es) Derivados de camptotecina.
ATE194597T1 (de) Substituierte salizylsäure zur behandlung von autoimmunkrankheiten
NO911787D0 (no) Peptidaminer samt fremgangsmaate for fremstilling derav.
SE9100342D0 (sv) Novel steroid esters
GR3032220T3 (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation
NZ334906A (en) A sulphonamido pentanoic acid derivative useful as an interleukin-1-beta converting enzyme inhibitor
ATE14226T1 (de) Cyclische octapeptide und pharmazeutische praeparate davon, sowie verfahren zur herstellung derselben und ihre anwendung.
AR006523A1 (es) Compuestos ciclicos, inhibidores de la adhesion
AR014964A1 (es) Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones
NO923911L (no) Nye 17beta-substituerte aza-androstan derivater
DE69013742D1 (de) Peptide und diese Peptide enthaltende Wirkstoffe gegen Dementia.
HU9301520D0 (en) Methods for producing cyclopeptides promoting absorption of peptides and albumins through mucous membrane as well as pharmaceutical preparations containing said compounds as auxiliary agents
KR890701545A (ko) 건선치료를 위한 제약학적 조성물
DK0513613T3 (da) Hidtil ukendte polypeptider med affinitet for lipopolysaccharider og anvendelse heraf
ATE89264T1 (de) Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen.
NO894720L (no) Farmasoeytisk aktivt protein.
DE68917211D1 (de) N-(5,6,7,8-Tetrahydropyrido(2,3-d)pyrimidin-6-yl-alkanoyl)-glutaminsäure-Derivate.
KR970704462A (ko) 각막치료제(corneal therapeutic agent)
ES2074264T3 (es) Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen.
TR200603675T2 (tr) Seçilmiş amino asit-çinko komplekslerin anti-malaryal olarak kullanımı